Home About Us Peptide & Protein biosimilars Antibody Biosimilar Regulatory Strategy Contact

R&D-driven manufacturing delivered globally

Scaling complex biosimilar development through deep chemical expertise, integrated software, and high-precision manufacturing capacity.

Our Development Pipeline
01 Molecular Assessment and Feasibility
02 Process Development
03 Structural and Physiochemical Development
04 Comparability and Biosimilarity Assessment
05 Regulatory Support

Trusted by 50+ Industry Partners

Who We Are

An initiative by Mumbai Biocluster, BiosimilarIndia serves as a premier collaborative hub for biosimilar innovation. Established in strategic partnership with Institute of Chemical Technology (ICT), Mumbai, we provide comprehensive, end-to-end development services through high-precision science.

1

Accurate and accelerated delivery

Right-sized infrastructure and coordinated workflows across the ecosystem mean faster development cycles - without compromising the science behind them

2

Heavily de-risked Biotherapeutic development

Every program is built on validated processes and orthogonal analytical checks - surfacing risks early, not after they've become costly delays.

3

Transparent, Collaborative Partnership

Study design, data, and decisions are shared openly at every stage - so you stay in control of your program, not just informed about it after the fact.

4

Regulatory Pragmatism

Pre-submission consultation support across FDA, EMA, and CDSCO - so dossiers are built for agency acceptance from day one, not retrofitted after review..

How we can help you

We provide comprehensive end-to-end solutions for biosimilar development, from analytical characterization to process optimization and regulatory support. Our services include:

Monoclonal Antibody (mAb) Biosimilars

End-to-End Bioprocess & Characterization

  • CHO Cell Line Development
  • Upstream Process Development
  • Downstream Process Development
  • Analytical & Bioanalytical Characterization (mAbs)
Cell Line Process Development Characterization mAbs
Learn More

Peptide & Protein biosimilars

Analytical & Bioanalytical Services

  • Peptide Sameness & Structural Characterization
  • Higher Order Structure (HOS) Analysis
  • Bioanalytical & Functional Characterization
  • Formulation & Stability Studies
Peptide Protein Characterization HOS Stability
Learn More

Regulatory Strategy for Clinical Waiver

Regulatory & CMC Advisory

  • Totality-of-Evidence dossier building
  • Statistical similarity assessment
  • CMC module preparation (Module 3)
  • Pre-submission consultation support
Regulatory CMC Clinical Waiver Strategy Compliance
Learn More